- Home
- PLYM vs SVA Comparison
PLYM vs SVA Comparison
Compare PLYM & SVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLYM
- SVA
- Stock Information
- Founded
- PLYM 2011
- SVA N/A
- Country
- PLYM United States
- SVA
- Employees
- PLYM N/A
- SVA 3261
- Industry
- PLYM Real Estate Investment Trusts
- SVA
- Sector
- PLYM Real Estate
- SVA
- Exchange
- PLYM Nasdaq
- SVA NYSE
- Market Cap
- PLYM 1.1B
- SVA N/A
- IPO Year
- PLYM 2017
- SVA N/A
- Fundamental
- Price
- PLYM $21.07
- SVA $6.47
- Analyst Decision
- PLYM Buy
- SVA
- Analyst Count
- PLYM 7
- SVA 0
- Target Price
- PLYM $25.57
- SVA N/A
- AVG Volume (30 Days)
- PLYM 234.8K
- SVA N/A
- Earning Date
- PLYM 11-06-2024
- SVA N/A
- Dividend Yield
- PLYM 4.59%
- SVA N/A
- EPS Growth
- PLYM N/A
- SVA N/A
- EPS
- PLYM 0.54
- SVA N/A
- Revenue
- PLYM $199,463,000.00
- SVA N/A
- Revenue This Year
- PLYM N/A
- SVA N/A
- Revenue Next Year
- PLYM $6.32
- SVA N/A
- P/E Ratio
- PLYM $38.99
- SVA N/A
- Revenue Growth
- PLYM 2.60
- SVA N/A
- 52 Week Low
- PLYM $19.21
- SVA N/A
- 52 Week High
- PLYM $25.55
- SVA N/A
- Technical
- Relative Strength Index (RSI)
- PLYM 36.31
- SVA N/A
- Support Level
- PLYM $21.49
- SVA N/A
- Resistance Level
- PLYM $22.12
- SVA N/A
- Average True Range (ATR)
- PLYM 0.37
- SVA 0.00
- MACD
- PLYM -0.01
- SVA 0.00
- Stochastic Oscillator
- PLYM 26.32
- SVA 0.00
About PLYM Plymouth Industrial REIT Inc.
Plymouth Industrial REIT Inc is a full-service, vertically integrated, self-administered, and self-managed Maryland corporation. It is focused on the acquisition, ownership, and management of single and multi-tenant Class B industrial properties, including distribution centers, warehouses, and light industrial properties, located in secondary and primary markets across the United States. The company has one reportable segment, which is Industrial properties. The majority of its property portfolio is spread across Florida, Ohio, Indiana, Tennessee, Illinois and Georgia, among others. It receives income primarily from the rental revenue through its properties.
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.